81 – 90 of 97
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Vitamin D in normal and pathological parathyroid glands: New prospects for treating hyperparathyroidism (Review)
(
- Contribution to journal › Scientific review
- 2004
-
Mark
Reduced p18INK4c, p21CIP1/WAF1 and p27KIP1 mRNA levels in tumours of primary and secondary hyperparathyroidism
(
- Contribution to journal › Article
- 2003
-
Mark
Intragenic allelic loss and promoter hypermethylation of the RIZ1 tumor suppressor gene in parathyroid tumors and pheochromocytomas
(
- Contribution to journal › Article
- 2002
-
Mark
Exclusive underexpression of vitamin D receptor exon 1f transcripts in tumors of primary hyperparathyroidism
(
- Contribution to journal › Article
-
Mark
Multiple endocrine neoplasia type 1 polymorphism D418D is associated with sporadic primary hyperparathyroidism
(
- Contribution to journal › Article
-
Mark
Underexpression of Gcm2, a master regulatory gene of parathyroid gland development, in adenomas of primary hyperparathyroidism
(
- Contribution to journal › Article
-
Mark
25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands
(
- Contribution to journal › Article
-
Mark
Allelic loss in clinically and screening-detected primary hyperparathyroidism
(
- Contribution to journal › Article
-
Mark
Increased 25-hydroxyvitamin D3 1alpha-hydroxylase and reduced 25-hydroxyvitamin D3 24-hydroxylase expression in parathyroid tumors--new prospects for treatment of hyperparathyroidism with vitamin d
(
- Contribution to journal › Article
- 2001
-
Mark
Primär hyperparatyreoidism vanligt hos postmenopausala kvinnor. Identifiering av genetiska riskfaktorer kan ge individanpassad behandling
(
- Contribution to specialist publication or newspaper › Specialist publication article